CAVE CREEK, AZ--(Marketwired - Jun 15, 2015) - Endexx Corporation's (
After the immense success of Canna Joos at the Cannabis Cup in April, CBD Health Solutions has expanded its highly unique product line with the launch of two more high-demand products: Canna Flakes© and Canna Drip©. Canna Flakes© are a dry, crystal-like CBD concentrate that can be either ingested or vaporized. Canna Flakes© are derived from non-GMO, imported organic European hemp. The flakes are CO2 extracted and are free of contaminants and additives and represent the highest level of potency, consistency and quality of any CBD product on the market. The newest product, Canna Drip, is an ultra-stable CBD-infused vape concentrate that allows individuals to mix their own CBD flavors and concentrations into e-juice with ease and precision.
In the past month, CBD Health Solutions has also entered into a partnership with Aqua Blitzed™ to co-develop CBD-infused beverages. Progress was made much quicker than expected during the creation of this product, and CBD Health Solutions and Aqua Blitzed™ have successfully submitted a Peach Nectarine flavored and infused zero calorie sparkling water into the category for Best CBD Edible at the NorCal Medical Cannabis Cup.
Upon completion of the Cannabis Cup, marketing for CBDHS' unique products will begin to expand aggressively with the completion of its initial product line. To complete the line, CBDHS will be launching highly sought after CBD-infused Keurig Cups (K-Cups) as it continues to build out its premium hemp oil product line. The K-Cups will be sold in coffee, apple cider, and hot chocolate flavors. All of our premium hemp-based products can be purchased from our website: www.cbdhealthsolutions.com.
Endexx provides innovative medical marijuana management and technology solutions. Endexx with its collaboration partners and consultants develops and distributes two consumable product lines derived from industrial hemp that is organic and naturally rich in phytocannabinoids. The company has two technology products and services that launched in 2014 -- the M3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through "seed to sale" inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical grade marijuana to maintain compliance with the laws of National and State governments, and local regulatory bodies, as well as, provide a smooth transition to the eventual Federal mandates. The Autospense™ is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. Websites are www.cbdhealthsolutions.com, www.cbdunlimited.com, www.endexx.com, www.m3hub.com.
Safe Harbor Notice
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.